From major journals, first or last author from the Institute for Cancer Research
Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J(2026) TCR T cells targeting IgA- and IgG-expressing multiple myeloma Blood(in press) DOI 10.1182/blood.2025031897, PubMed 41770814
Sveen A, Bergsland CH, Niederdorfer B, Berstad AE, Bjerkehagen B, Boye K, Guren TK, Lothe RA(2026) Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trial NPJ Precis Oncol(in press) DOI 10.1038/s41698-026-01303-6, PubMed 41760889
Rakaee M, Nassar AH, Tafavvoghi M, Jabar F, Bou Farhat E, Adib E, Andersen S, Busund LR, Pøhl M, Helland Å, Gusev A, Ricciuti B, Sholl LM, Donnem T, Kwiatkowski DJ(2026) Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer JAMA Oncol(in press) DOI 10.1001/jamaoncol.2025.6430, PubMed 41678173
Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J(2026) TCR T cells targeting IgA- and IgG-expressing multiple myeloma Blood(in press) DOI 10.1182/blood.2025031897, PubMed 41770814
Apostol AI, Gronwald J, Cybulski C, Kim RH, Møller P, Karlan BY, Bordeleau L, Schrader I, Ramón Y Cajal T, Pal T, Eisen A, Singer CF, Couch FJ, Zakalik D, Metcalfe K, Olopade O, Tung N, Fruscio R, Foulkes WD, Aeilts A, Sun P, Lubinski J, Narod SA, Kotsopoulos J, Hereditary Breast Cancer Clinical Study Group(2026) Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2 J Clin Oncol, JCO2501648(in press) DOI 10.1200/JCO-25-01648, PubMed 41762747
Sveen A, Bergsland CH, Niederdorfer B, Berstad AE, Bjerkehagen B, Boye K, Guren TK, Lothe RA(2026) Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trial NPJ Precis Oncol(in press) DOI 10.1038/s41698-026-01303-6, PubMed 41760889
